Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel

BACKGROUND: In December 2020, the Israeli Ministry of Health launched a national vaccination campaign against SARS-CoV-2. Concomitant sporadic reports on anaphylactic responses in other countries raised safety concerns at the outset of this operation. OBJECTIVE: To characterize reports on allergic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Anis, Emilia, Preis, Sharon Alroy, Cedar, Noa, Tal, Yuval, Hershkowitz, Isca, Hershko, Alon Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356746/
https://www.ncbi.nlm.nih.gov/pubmed/35872216
http://dx.doi.org/10.1016/j.jaip.2022.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356746/
https://www.ncbi.nlm.nih.gov/pubmed/35872216
http://dx.doi.org/10.1016/j.jaip.2022.07.012

Ejemplares similares